HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$46.20
Day range
$45.84 - $47.35
Year range
$19.45 - $53.27
Market cap
3.36B USD
Avg Volume
657.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 11.48M | -55.26% |
Operating expense | 17.64M | 1.57% |
Net income | -76.61M | -82.15% |
Net profit margin | -667.60 | -307.12% |
Earnings per share | -0.95 | -63.79% |
EBITDA | -83.17M | -67.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 665.44M | 30.49% |
Total assets | 1.13B | 36.93% |
Total liabilities | 159.59M | 13.11% |
Total equity | 971.48M | — |
Shares outstanding | 71.50M | — |
Price to book | 3.36 | — |
Return on assets | -20.63% | — |
Return on capital | -21.91% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -76.61M | -82.15% |
Cash from operations | -59.88M | -39.47% |
Cash from investing | 60.02M | 283.72% |
Cash from financing | 245.73M | 17,302.69% |
Net change in cash | 245.86M | 1,049.94% |
Free cash flow | -33.05M | -112.83% |
About
Founded
2015
Headquarters
Website
Employees
218
